What is ADMA stock price today?

ADMA (ADMA Biologics Inc) stock is trading at $17.59 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ADMA stock going up or down today?

ADMA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ADMA stock now?

The decision to buy ADMA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ADMA a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ADMA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ADMA stock overvalued or undervalued?

ADMA currently trades at a P/E ratio of 20.45 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if ADMA is fairly priced.

What is ADMA's P/E ratio?

ADMA has a price-to-earnings (P/E) ratio of 20.45, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is ADMA's market cap?

ADMA (ADMA Biologics Inc) has a market capitalization of $4.20 billion, making it a small-cap stock.

What is ADMA's price to book ratio?

ADMA trades at a price-to-book (P/B) ratio of 9.55, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ADMA pay dividends?

ADMA does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ADMA's dividend yield?

ADMA does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ADMA stock a good long-term investment?

ADMA's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ADMA's revenue growth rate?

ADMA has shown revenue growth of 0.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, ADMA is profitable with a profit margin of 0.4%. This indicates the company generates 0.4 cents of profit for every dollar of revenue.

What are the risks of investing in ADMA?

Key risks for ADMA include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ADMA compare to its competitors?

Compare ADMA to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ADMA's performance and positioning.

What is ADMA's stock price target for 2026?

Our AI model provides price targets for ADMA based on fundamental analysis: Bull case $22.87 (+30%), Base case $20.23 (+15%), Bear case $15.83 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ADMA?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ADMA. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ADMA's next earnings report?

ADMA reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ADMA - ADMA Biologics Inc

NYSE * Healthcare * Biotechnology

$17.59

+$0.28 (+1.62%)

About ADMA Biologics Inc

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

ADMA Key Statistics

Market Cap

$4.20B

P/E Ratio

20.45

P/B Ratio

9.55

EPS

$0.86

Revenue Growth

+0.1%

Profit Margin

0.4%

Employees

677

How ADMA Compares to Peers

ADMA has the highest profit margins in Biotechnology

ADMA ranks 2nd in revenue growth vs peers

ADMA is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ADMA(This stock)	$4.20B	20.5	0%	0.4%	-
AMGNAmgen Inc	$177.92B	25.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$154.99B	19.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$113.16B	31.1	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$77.69B	17.6	0%	0.3%	vs REGN
BIIBBiogen Inc	$24.12B	15.0	0%	0.2%	vs BIIB

ADMA Biologics Inc Company Information

Headquarters: 465 State Route 17, Ramsey, NJ, United States, 07446, undefined
Website: www.admabiologics.com
Sector: Healthcare
Industry: Biotechnology

ADMA - ADMA Biologics Inc

About ADMA Biologics Inc

ADMA Key Statistics

How ADMA Compares to Peers

ADMA Biologics Inc Company Information

ADMA Lician Score

ADMA Financial Snowflake

Upcoming Events for ADMA